On August 22, 2024, Lawyer Ye Ping, Secretary of the Party Branch of Shanghai Liu Chunlei Law Firm (hereinafter referred to as "Changlei Law Firm"), serving as the standing legal counsel for Shanghai Tongjitang Pharmaceutical Co., Ltd. (hereinafter referred to as "Tongjitang Pharmaceutical"), was invited to conduct a "Corporate Compliance Special Training" for the company. More than 20 senior and middle-level managers from Tongjitang Pharmaceutical attended the session.
Centering on the theme of "Corporate Compliance," Lawyer Ye Ping drew upon her extensive professional knowledge and practical experience to explain the fundamental connotations, core essentials, and historical evolution of corporate compliance in an accessible manner. She covered the challenges and practices of compliance management, compliance risk control systems, and future trends. Specifically, regarding the compliance risk control system, Lawyer Ye utilized the unique "Chunlei 6+1" Risk Control System, developed by Changlei Law Firm based on years of case-handling experience. She analyzed the seven major sectors of an enterprise: "Shareholders and Management, Finance and Taxation, Assets, Operations, Management, Investment, and Core Competitiveness." Through the presentation and analysis of numerous cases, she vividly revealed that enterprises and employees must remain vigilant across all areas and the entire chain of production, operations, and management. They must adhere to the compliance bottom line, continuously enhance awareness of lawful and honest operations, and effectively improve the ability to prevent and resolve legal risks. This aims to forge corporate compliance into a "Golden Shield" for the enterprise, effectively resisting external risks and safeguarding healthy development. During the interactive session, Lawyer Ye Ping listened attentively to questions and provided practical and effective legal advice.
After the meeting, the person in charge of Tongjitang Pharmaceutical stated that this training not only deepened the understanding of corporate compliance management among senior and middle-level managers but also promoted communication and collaboration within the team. The session marked a solid step forward in the construction of a compliance management system. In the future, Tongjitang Pharmaceutical will unswervingly strengthen the compliance system, integrate compliance management into every aspect of operations, continuously improve risk management capabilities, and propel compliance management onto a more stable and efficient development track.
On June 24, 2024, Tongjitang Pharmaceutical and Changlei Law Firm signed a standing legal counsel service agreement, with Managing Partner Liu Changlei, Secretary Ye Ping, and Lawyer Wang Yuqian serving as the company's standing legal counsel. Since the cooperation began, Changlei Law Firm has provided service support in daily legal consultation, contract review, compliance construction, and legal training, receiving high praise from the company.
With the continuous development and improvement of the market economy and increasingly frequent economic activities among enterprises, Changlei Law Firm will continue to actively participate in publicizing and optimizing the business environment and assisting the inheritance and innovative development of Traditional Chinese Medicine enterprises.
About Shanghai Tongjitang Pharmaceutical Co., Ltd.
Shanghai Tongjitang Pharmaceutical Co., Ltd. (hereinafter referred to as "Shanghai Tongjitang") was established in August 2002. In October 2016, it was officially acquired by China National Traditional Chinese Medicine Co., Ltd., a subsidiary of China National Pharmaceutical Group Co., Ltd. (Sinopharm), becoming a Chinese herbal decoction pieces enterprise under the central enterprise sequence.